Dr Danny Con
Clinical (Lecturer)
Department of Medicine
121 Scholarly works
0 Projects
HIGHLIGHTS
2026
Journal article
Rethinking the dose: A Bayesian meta-analysis of infliximab intensification in acute severe ulcerative colitis.
DOI: 10.1093/ibd/izag0422026
Journal article
Response
DOI: 10.1016/j.gie.2025.10.0172026
Journal article
2026
Journal article
Editorial: Predicting Hepatocellular Carcinoma Development in Chronic Hepatitis B Patients With Metabolic Dysfunction—Do Existing Scores Clear the Bar?
DOI: 10.1111/apt.703712026
Journal article
Early Infliximab Levels and Clearance Predict Outcomes After Infliximab Rescue in Acute Severe Ulcerative Colitis: Results From PREDICT-UC
DOI: 10.1053/j.gastro.2025.07.0202026
Journal article
P0684 Rethinking the Dose: A Bayesian Meta-Analysis of Infliximab Intensification in Acute Severe Ulcerative Colitis
DOI: 10.1093/ecco-jcc/jjaf231.8652026
Journal article
Monocyte Distribution Width Differentiates Bacterial Enterocolitis from Acute Severe Ulcerative Colitis in the Emergency Department
DOI: 10.1007/s10620-026-09786-w
RECENT SCHOLARLY WORKS
2025
Journal article
Editorial: Redefining Safety in Post-Liver Transplant IBD—Why Therapeutic Effectiveness Is the Ultimate Shield. Authors' Reply
DOI: 10.1111/apt.703412025
Journal article
Systemic Biologics Have Similar Safety to Vedolizumab in Inflammatory Bowel Disease Patients Following Liver Transplantation
DOI: 10.1111/apt.702832025
Journal article
S2028 Escalating the Dosage: A Meta-Analysis Comparing Standard and Intensified Infliximab for ASUC
DOI: 10.14309/01.ajg.0001135572.07563.4e